Characterization of low right atrial isthmus as the slow conduction zone and pharmacological target in typical atrial flutter

Circulation

Volumn 96, Issue 8, 1997, Pages 2601-2611

  Tai, Ching Tai ^a   Chen, Shih Ann ^a,b   Chiang, Chern En ^a   Lee, Shih Huang ^a   Ueng, Kwo Chang ^a   Wen, Zu Chi ^a   Huang, Jin Long ^a   Chen, Yi Jen ^a   Yu, Wen Chung ^a   Feng, An Ning ^a   Chiou, Chuen Wang ^a   Chang, Mau Song ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Atrial flutter; Conduction; Procainamide; Sotalol

Indexed keywords

PROCAINAMIDE; SOTALOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HEART ATRIUM CONDUCTION; HEART ATRIUM FLUTTER; HEART CYCLE; HEART MUSCLE REFRACTORY PERIOD; HEART RIGHT ATRIUM; HUMAN; MALE; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PRIORITY JOURNAL;

EID: 0030773236     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.8.2601     Document Type: Article

References (39)

1. Klein GJ, Guiraudon GM, Sharma AD, Milstein S. Demonstration of macroreentry and feasibility of operative therapy in the common type of atrial flutter. Am J Cardiol. 1986;57:587-591.
2. Cosio FG, Lopez-Gil M, Goicolea A, Arribas F. Electrophysiologic studies in atrial flutter. Clin Cardiol. 1992;15:667-673.
3. Olgin JE, Kalman JM, Fitzpatrick AP, Lesh MD. Role of right atrial endocardial structures as barriers to conduction during human type I atrial flutter: activation and entrainment mapping guided by intracardiac echocardiography. Circulation. 1995;92:1839-1848.
4. Kalman JM, Olgin JE, Saxon LA, Fisher WG, Lee RJ, Lesh MD. Activation and entrainment mapping defines the tricuspid annulus as the anterior barrier in typical atrial flutter. Circulation. 1996;94: 398-406.
5. Nakagawa H, Lazzara R, Khastgir T, Beckman KJ, McClelland JH, Imai S, Pitha JV, Becker AE, Arruda M, Gonzales MD, Widman LE, Rome M, Neuhauser J, Wang X, Calame JD, Goudeau MD, Jackman WM. Role of the tricuspid annulus and the eustachian valve/ridge on atrial flutter: relevance to catheter ablation of the septal isthmus and a new technique for rapid identification of ablation success. Circulation. 1996;94:407-424.
6. Poty H, Saoudi N, Aziz AA, Nair M, Letac B. Radiofrequency catheter ablation of type 1 atrial flutter: prediction of late success by electrophysiological criteria. Circulation. 1995;92:1389-1392.
7. Cauchemez B, Haissaguerre M, Fischer B, Thomas O, Clementy J, Coumel P. Electrophysiological effects of catheter ablation of inferior vena cava-tricuspid annulus isthmus in common atrial flutter. Circulation. 1996;93:284-294.
8. Chen SA, Chiang CE, Wu TJ, Tai CT, Lee SH, Cheng CC, Chiou CW, Ueng KC, Wen ZC, Chang MS. Radiofrequency catheter ablation of common atrial flutter: comparisons between electrophysiologically guided focal ablation technique and linear ablation technique. J Am Coll Cardiol. 1996;27:860-868.
9. Cosio FG, Lopez-Gil M, Goicolea A, Arribas F, Barroso JL. Radiofrequency ablation of the inferior vena cava-tricuspid valve isthmus in common atrial flutter. Am J Cardiol. 1993;71:705-709.
10. Kirkorian G, Moncada E, Chevalier P, Canu G, Claudel JP, Bellon C, Lyon L, Touboul P. Radiofrequency ablation of atrial flutter: efficacy of an anatomically guided approach. Circulation. 1994;90:2804-2814.
11. Fischer B, Haissaguerre M, Garrigues S, Poquet F, Gencel L, Clementy J, Marcus FI. Radiofrequency catheter ablation of common atrial flutter in 80 patients. J Am Coll Cardiol. 1995;25: 1365-1372.
12. Boineau JP, Schuessller RB, Mooney CR, Miller CB, Wylds AC, Hudson RD, Borremans JM, Brockus CW. Natural and evoked atrial flutter due to circus movement in dogs. Am J Cardiol. 1980; 45:1167-1181.
13. Schoels W, Gough WB, Restivo M, El-sherif N. Circus movement atrial flutter in the canine sterile pericarditis model: activation patterns during initiation, termination, and sustained reentry in vivo. Circulation. 1990;67:35-50.
14. Yamashita T, Oikawa N, Inoue H, Murakawa Y, Nakajima T, Usui M, Ajiki K, Ohkawa S, Sugimoto T. Slow abnormal conduction in the low right atrium: its anatomic basis and relevance to atrial reentry. Am Heart J. 1994;127:353-359.
15. Olshansky B, Okumura K, Hess PG, Waldo AL. Demonstration of an area of slow conduction in human atrial flutter. J Am Coll Cardiol. 1990;16:1639-1648.
16. Cosio FG, Gil ML, Arribas F, Palacios J, Goicolea A, Nunez A. Mechanisms of entrainment of human common flutter studied with multiple endocardial recordings. Circulation. 1994;89:2117-2125.
17. Tai CT, Chen SA, Chiang CE, Lee SH, Ueng KC, Wen ZC, Chen YJ, Yu WJ, Huang JL, Chiou CW, Chang MS. Electrophysiologic characteristics and radiofrequency catheter ablation in patients with clockwise atrial flutter. J Cardiovasc Electrophysiol. 1997;8:24-34.
18. Stambler BS, Wood MA, Ellenbogen KA. Pharmacologic alterations in human type I atrial flutter cycle length and monophasic action potential duration. J Am Coll Cardiol. 1996;27:453-461.
19. Sung RJ, Tan HL, Karagounis L, Hanyok JJ, Falk R, Platia E, das G, Hardy SA, for the Sotalol Multicenter Study Group. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blinded, placebo-controlled study. Am Heart J. 1995;129:739-748.
20. Saumarez RC, Parker J, Camm J. Geometrically accurate activation mapping of the atrioventricular node region during surgery. J Am Coll Cardiol. 1992;19:601-606.
21. Papageorgiou P, Monahan K, Boyle NG, Seifert MJ, Beswick P, Zebede J, Epstein LM, Josephson ME. Site-dependent intra-atrial conduction delay: relationship to initiation of atrial fibrillation. Circulation. 1996;94:384-389.
22. Spach MS, Dolber PC, Heidlage JF. Influence of the passive anisotropic properties on directional differences in propagation following modification of the sodium conductance in human atrial muscle: a model of reentry based on anisotropic discontinuous propagation. Circ Res. 1988;62:811-832.
23. Spach MS, Dolber PC. Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle: evidence for electrical uncoupling of side-to-side fiber connections with increasing age. Circ Res. 1986;58: 356-371.
24. Rensma PL, Allessie MA, Lammers WJEP, Bonke FIM, Schalij MJ. Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ Res. 1988;62:395-410.
25. Josephson ME. Atrial flutter and fibrillation. In: Clinical Cardiac Electrophysiology: Techniques and Interpretations. Philadelphia, Pa: Lea & Febiger; 1993:275-310.
26. Attuel P, Pellerin D, Gaston J. Latent atrial vulnerability: new means of electrophysiologic investigations in paroxysmal atrial arrhythmia. In: Attuel P, ed. The Atrium in Health and Disease. Armonk, NY: Futura Publishing Co Inc; 1989.
27. Buxton AE, Waxman HL, Marchlinski FE, Josephson ME. Atrial conduction: effects of extrastimuli with and without atrial dysrhythmia. Am J Cardiol. 1984;54:755-761.
28. Wu KM, Hoffman BF. Effect of procainamide and N-acetylprocainamide on atrial flutter: studies in vivo and in vitro. Circulation. 1987;6:1397-1408.
29. Schoels W, Yang H, Gough WB, El-Sherif N. Circus movement atrial flutter in the canine sterile pericarditis model: differential effects of procainamide on the components of the reentrant pathway. Circ Res. 1991;68:1117-1126.
30. Cha Y, Wales A, Wolf P, Shahrokni S, Sawhney N, Feld GK. Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide compared to the class IA antiarrhythmic drug quinidine in experimental canine atrial flutter: role of dispersion of refractoriness in antiarrhythmic efficacy. J Cardiovasc Electrophysiol. 1996;7:809-827.
31. Spinelli W, Hoffman BF. Mechanisms of termination of reentrant atrial arrhythmias by class I and class III antiarrhythmic agents. Circ Res. 1989;65:1565-1579.
32. Boyden PA, Graziano JN. Activation mapping of reentry around an anatomical barrier in the canine atrium: observations during the action of the class III agent, d-sotalol. J Cardiovasc Electrophysiol. 1996;7:612-624.
33. Boyden PA. Effects of pharmacologic agents on induced atrial flutter in dogs with right atrial enlargement. J Cardiovasc Pharmacol. 1986;8:170-177.
34. Feld GK, Venkatesh N, Singh BN. Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction. Circulation. 1986;74:197-204.
35. Inoue H, Yamashita T, Nozaki A, Sugimoto T. Effects of antiarrhythmic drugs on canine atrial flutter due to reentry: role of prolongation of refractory period and depression of conduction to excitable gap. J Am Coll Cardiol. 1991;18:1098-1104.
36. Stambler BS, Wood MA, Ellenbogen KA, Perry KT, Wakefield LK, VanderLugt JT, for the Ibutilide Repeat Dose Study Investigators. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Circulation. 1996; 94:1613-1621.
37. Antman EM, Beamer AD, Cantillon CO, McGowan N, Friedman PL. Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs. J Am Coll Cardiol. 1990;15:698-707.
38. Crijns HJ, Van Gelder IC, Van Gilst WH, Hillege H, Gosselink AM, Lie KI. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter. Am J Cardiol. 1991;68:335-341.
39. Maragnes P, Tipple M, Fournier A. Effectiveness of oral sotalol for treatment of pediatric arrhythmias. Am J Cardiol. 1992;69:751-754.